secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2024-06-18T23:59:59+00:00
Accession:  0001079973-24-000910
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health receives Nasdaq exception until July 22 to effect reverse stock split and regain $1 bid price
--------------------------------------------------------------------------------

- Nasdaq Hearings Panel granted Nutex exception until July 22, 2024 to execute reverse split and regain $1.00 minimum bid.
- Stockholders approved reverse stock split (1-for-2 to 1-for-16); board to set exact ratio within one year.
- Company had already done a 1-for-15 reverse split in April 2024 but still not compliant; delisting if not cured by July 22.
- Annual meeting also elected all director nominees, approved executive compensation, and ratified Marcum LLP as auditor for FY2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000107997324000910/0001079973-24-000910-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000107997324000910/nutx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-24-000910

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer